 |
|
| Blog results | Results 1 - 10 of about 44,808 for metastatic breast cancer. (0.17 seconds) |
| Sorted by relevance Sort by date |
| Related Blogs: | Metastatic Breast Cancer Awareness Day - http://www.injuryboard.com/national-news/metastatic-breast-cancer-awareness-day.aspx?googleid=272602 The Battle in Seattle: Stage IV Metastatic Breast Cancer and other ... - http://teamhyra.blogspot.com/ Imaging study shows brain abnormalities in chemotherapy patients - http://www.mbcnetwork.org/blog/index.php Discussing Breast Cancer - http://www.discussingbreastcancer.com/ | |
| 3 hours ago by vizcarraactually The Withdraw II study, sponsored by American BioScience, included 106 patients with reformist metastatic breast cancer whose disability had progressed while being treated with TAXOL or Taxotere in the metastatic setting, ... vizcarraactually - http://vizcarraactually.devpad.in/ |
| 13 hours ago by admin Occasionally, breast cancer presents as metastatic disease, that is, cancer that has spread beyond the original organ. Metastatic breast cancer will cause symptoms that depend on the location of metastasis. Common sites of metastasis ... Healthy Tips - http://www.chacoastronomy.com/ |
| 9 Dec 2009 NEW YORK (Reuters Health) – New research suggests that high-dose vitamin D can be safely given to breast cancer patients with bone metastases, but it will not affect palliation or bone resorption. The potential of vitamin D for breast ... The Doctor's Channel - http://www.thedoctorschannel.com/ [ More results from The Doctor's Channel ] |
| 16 Dec 2009 by mjames 69% of patients experienced a partial or complete reduction of detectable cancer following treatment. Overall response rate was 70% among patients who had not been previously treated for metastatic breast cancer and 68% among patients ... CancerConsultants - http://www.cancerconsultants.com/ [ More results from CancerConsultants ] |
| 5 hours ago RIBBON-2 results demonstrated that adding bevacizumab to chemotherapy as a second-line treatment for metastatic breast cancer significantly improved progression-free survival. "Potentially, we have another biologic agent that can ... ecancer news - http://www.ecancermedicalscience.com/ [ More results from ecancer news ] |
| 14 Dec 2009 A new antibody-drug compound shrank or halted the growth of metastatic breast tumours in almost half of a group of patients whose HER2-positive cancer had become resistant to standard therapies, according to early data from a ... Science Centric | News - http://www.sciencecentric.com/ [ More results from Science Centric | News ] |
| 17 Dec 2009 Safety and efficacy of neratinib (HKI-272) in combination with paclitaxel in ErbB2+ metastatic breast cancer. Presented at the 32nd CTRC-AACR San Antonio Breast Cancer Symposium. December 9-13, 2009. San Antonio, TX. Abstract 5081. ... Breast Cancer News - http://ww5.komen.org/News.aspx [ More results from Breast Cancer News ] |
| 8 Dec 2009 A total of 2091 women with metastatic breast cancer diagnosed between 1991 to 2007 and with known HER2 status and who had not received trastuzumab in the adjuvant setting, were identified. Disease was classified into the following three ... NeLM - News - http://www.nelm.nhs.uk/en/NeLM-Area/News/ - References [ More results from NeLM - News ] |
| 15 Dec 2009 A new targeted cancer drug called T-DM1 has been shown to shrink tumors in women with metastatic breast cancer after an average of seven other drugs, including Herceptin, failed. WebMD Health - http://www.webmd.com/ - References [ More results from WebMD Health ] |
| 16 Dec 2009 "These agents appear to make bone less hospitable to breast cancers," Chlebowski said. To learn more about Dr. Chlebowski's research, click here. New Approaches to Treating Metastatic Breast Cancer Show Encouraging Results ... Stand Up To Cancer - http://www.standup2cancer.org/blog_su2c/ |
Stay up to date on these results:
| Google Home - About Google Blog Search Beta - Information for Blog Authors |
